Background Image
Table of Contents Table of Contents
Previous Page  374 / 400 Next Page
Information
Show Menu
Previous Page 374 / 400 Next Page
Page Background

MISCELLANEOUS LAWS

374

MISCELLANEOUS LAWS

LEGEND DRUGS; ANABOLIC

STEROIDS

TITLE 16

ARTICLE 18

Chapter 2. Definitions [Portions omitted].

16-18-2-5.5.

“Adult stem cell” defined.

16-18-2-15.

“Anabolic steroid” defined.

16-18-2-56.5.

“Cloning” defined.

16-18-2-78.

“Controlled premises” defined.

16-18-2-79.

“Controlled substance” defined.

16-18-2-101.

“Drug” defined.

16-18-2-102.

“Drug order” defined.

16-18-2-103.

“Drug sample” defined.

16-18-2-128.5. “Fetal stem cell” defined.

16-18-2-183.5. “Human embryo” defined.

16-18-2-194.

“Investigational or new drug” defined.

16-18-2-199.

“Legend drug” defined.

16-18-2-216.

“Manufacturer” defined.

16-18-2-223.

“Mechanical device” defined.

16-18-2-281.

“Pharmacist” defined.

16-18-2-288.

“Practitioner” defined.

16-18-2-289.

“Precursor” defined.

16-18-2-292.

“Prescription” defined.

16-18-2-321.

“Sale” defined.

16-18-2-365.

“Viability” defined.

16-18-2-374.

“Wholesaler” defined.

16-18-2-5.5. “Adult stem cell” defined.

“Adult stem cell”means an undifferentiated cell

that:

(1) is found in a differentiated tissue;

(2) is renewable; and

(3) yields specialized cell types with cer-

tain limitations of the tissue from which it

originated.

16-18-2-15. “Anabolic steroid” defined.

“Anabolic steroid,” ,” for purposes of IC 16-

42-19, means a material, compound, mixture, or

preparation that contains an anabolic steroid that

includes any of the following:

Chorionic gonadotropin

Clostebol

Dehydrochlormethyltestosterone

Ethylestrenol

Fluoxymesterone

Mesterolone

Metenolone

Methandienone

Methandro stenolone

Methyltestosterone

Nandrolone decanoate

Nandrolone phenpropionate

Norethandrolone

Oxandrolone

Oxymesterone

Oxymetholone

Stanozolol

Testosterone propionate

Testosterone-like related compounds.

16-18-2-56.5. “Cloning” defined.

(a) “Cloning” means the use of asexual repro-

duction to create or grow a human embryo from

a single cell or cells of a genetically identical

human.

(b) The term does not include:

(1) a treatment or procedure to enhance

human reproductive capability through the

manipulation of human oocytes or

embryos, including the following:

(A) In vitro fertilization.

(B) Gamete intrafallopian transfer.

(C) Zygote intrafallopian transfer; or

(2) the following types of stem cell

research:

(A) Adult stem cell.

(B) Fetal stem cell, as long as the bio-

logical parent has given written consent

for the use of the fetal stem cells.

(C) Embryonic stem cells from lines

that are permissible for use under appli-

cable federal law.

16-18-2-78. “Controlled premises” defined.

“Controlled premises,” for purposes of IC 16-

42-20-2, has the meaning set forth in IC 16-42-20-

2(a).

16-18-2-79. “Controlled substance” defined.

“Controlled substance,” for purposes of IC

16-42-21, has the meaning set forth in IC 16-42-

21-1.

16-18-2-101. “Drug” defined.

(a) “Drug,” for purposes of IC 16-42-1 through